High Quality 99% Antibiotics CAS 21462-39-5 Clindamycin Hydrochloride
Price | USD15.00 |
Packge | 1KG |
- Min. Order:1KG
- Supply Ability:10000
- Time:2021-12-01
Product Details
- Product NameClindamycin Hydrochloride
- CAS No.21462-39-5
- EINECS No.244-398-6
- MFC18H34Cl2N2O5S
- MW461.44
- AppearanceneatWhite to Off-White
- Melting point 141°C
- storage temp. 2-8°C
High Quality 99% Antibiotics CAS 21462-39-5 Clindamycin Hydrochloride
Clindamycin hydrochloride is suitable for Streptococcus, Staphylococcus and anaerobic bacteria (including Bacteroides, Clostridium perfringens, actinomyces), heavy infection caused by, such as aspiration pneumonia, empyema, lung abscess, osteomyelitis, abdominal infection, pelvic infection and septicemia.
Item | Specification | Result |
Assay | 99% | 99.68% |
Appearance | White powder | conforms |
Odor | Characteristic | conforms |
Taste | Characteristic | conforms |
Particle Size | NLT 100% Through 80 mesh | conforms |
Loss on Drying | <2.0% | 0.46% |
Heavy metals | ||
Total Heavy Metals | ≤10ppm | conforms |
Arsenic | ≤3ppm | conforms |
Lead | ≤3ppm | conforms |
Microbiological Tests | ||
Total Plate Count | ≤1000cfu/g | conforms |
Total Yeast & Mold | ≤100cfu/g | conforms |
E.Coli | Negative | Negative |
Salmonella | Negative | Negative |
·25kg/50kg/200kg/drum
M
Company Profile Introduction
-Hebei Guanlang Biotechnology Co.,Ltd
Contact:Zoey
Email:zoey@crovellbio.com
Whatsapp:+8619930503285
Wickr me: zoey456
Web:http://www.guanlang-group.com
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- CLINDAMYCIN HCL 95-99%
- Inquiry
- 2024-09-11
-
VIP1年
- Allmpus Laboratories Pvt Ltd
- Clindamycin Phosphate EP Impurity E 21462-39-5 95.65
- Inquiry
- 2024-08-29
-
VIP1年
- aistrifarma
- 21462-39-5 98%
- Inquiry
- 2024-03-13
-
VIP1年
- Alfa Omega Pharma
- Clindamycin hydrochloride 98%
- Inquiry
- 2024-02-17
-
VIP1年
- Vivimed Labs Ltd
- 21462-39-5 98%
- Inquiry
- 2024-01-08
- Since:2019-01-04
- Address: 2-2-1901, Huachenglvzhou 1st Phase. No.169 Shengli Nan Street,Qiaoxi District ,Shijiazhuang city, H
INQUIRY